- Ananworanich J, Gorowara M, Avihingsanon A, van Heesch N, Kerr S, Khongpetch C, Uanithirat A, Hill A, Ruxrungtham K, and Burger D. Low-Dose RAL at 400 mg Once Daily Achieves Adequate Plasma Concentrations in HIV-1-infected Thai Patients. [Abstract # 649]
http://retroconference.org/2011/PDFs/649.pdf
http://f1000.com/posters/view/document/1089232 - Chokephaibulkit K, Prasitsuebsai W, Wittawatmongkol O, Gorowara M, Phongsamart W, Wongsabut J, Vanprapar N, Puthanakit T, Burger D, Ananworanich J on behalf of the HIV-NAT 113 Study Group. Pharmacokinetics of darunavir/ritonavir in Asian HIV-1 infected children aged ≥ 6 years. [Poster # 714]
http://www.retroconference.org/2011/PDFs/714.pdf
http://f1000.com/posters/view/document/1089316 - Crane M, Rajasuriar R, Avihingsanon A, Matthews G, Skinner N, Tangkitvanich P, Dore GJ, Visvanathan K, Ruxrungtham K, Lewin SR. LPS, immune activation and liver disease in HIV-HBV co-infection. [Poster # 937]
http://retroconference.org/2011/PDFs/937.pdf - Avihingsanon A, Praditpornsilpa K , Wongsabut J, Clark A, Kerr SJ, Ubolyam S, Phanuphak P, Ananworanich J, Hiransuthikul N, Ruxrungtham K and HIV-NAT 006 study team. Prevalence and prognostic factors of chronic kidney disease in HIV-infected patients, HIV-NAT 006 cohort, Thailand. [Poster # 843]
http://www.natap.org/2011/CROI/croi_70.htm
http://retroconference.org/2011/PDFs/843.pdf - Bunupuradah T, Chetchotisakd P, Ananworanich J, Munsakul W, Jirajariyavet S, Kantipong P, Prasithsirikul W, Sungkanuparph S, Bowonwatanuwong C, Klinbuayaem V, Hirschel B, Bhakeecheep S, Ruxrungtham K and HIV STAR study team. Second line lopinavir/ritonavir monotherapy was inferior to tenofovir/lamivudine/lopinavir/ritonavir in patients who failed NNRTI-regimen: HIV STAR study. [Poster # 584]
http://retroconference.org/2011/PDFs/584.pdf
http://f1000.com/posters/view/document/1089259 - Puthanakit T, Kerr S, Bunupuradah T, Aurpibul L, Taecharoenkul S, Sirisanthana V, Law M, and Ananworanich J. Slow accumulation of thymidine analog and etravirine-associated mutations in NNRTI treated children with virologic failure. [Poster # S-159]
http://www.retroconference.org/2011/PDFs/720.pdf
http://f1000.com/posters/view/document/1089264 - Klinklom A, Puthanakit T, Gorowara M, Phasomsap C, Kerr S, Sriheara C, Ananworanich J, Burger D, Ruxrungtham K and Pancharoen C. Low Dose of Lopinavir/ritonavir Achieves Adequate Pharmacokinetic Parameters in HIV-Infected Thai Children. [Abstract # S-119]
http://www.retroconference.org/2011/PDFs/709.pdf
http://f1000.com/posters/view/document/1089260